The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Sepsis
Interventions
DRUG

Linezolid or Vancomycin

Whole blood samples from healthy subjects will be incubated with MRSA bacterium or bacterial toxins in the presence and absence of either linezolid or vancomycin. Final concentrations will mimic physiologic conditions. Platelets and leukocytes will be isolated and assayed for the presence of absence of activation and pre-mRNA splicing.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Utah

OTHER

NCT00811980 - The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents | Biotech Hunter | Biotech Hunter